โšก Diagnostic Procedure (Neurophysiology)

Electromyography (EMG): Nursing Guide

Electromyography (EMG) records muscle electrical activity โ€” often with nerve conduction studies โ€” to distinguish nerve injury from primary muscle disease when patients have weakness, cramps, numbness, or foot drop. Nurses protect validity with skin preparation, anticoagulation and pacemaker screening, warm extremities, and post-needle bleeding surveillance.

14 min read
Updated June 20, 2026
Medically Reviewed

Quick Facts

Category
Diagnostic procedure
Procedure type
Needle EMG ยฑ nerve conduction studies
Main nursing risk
Needle site bleeding or invalid skin prep
Turnaround
Often 30โ€“60 min when EMG

Key Takeaway

The main nursing priority with EMG is completing anticoagulation, bleeding-disorder, and implanted-device screening before needle study, ensuring lotion-free warm skin for valid recordings, and escalating new weakness or expanding hematoma after

Procedure Safety Checklist

Pre-procedure safety checks โ€” confirm each item before the patient leaves the ward or clinic.

  1. Correct patient, EMG/NCS order, and symptomatic limb(s)

  2. Anticoagulant, antiplatelet, and bleeding-disorder history disclosed

  3. Pacemaker, ICD, or other implanted electrical device history

  4. Skin free of lotions, creams, and oils on test day

  5. Extremities warm enough for valid nerve conduction recordings

  6. Progressive weakness, numbness, or foot drop documented with onset

  7. Loose clothing and jewelry removal from limbs being tested

  8. Medication list including pyridostigmine if applicable per local protocol

Sedation

Not usually required โ€” explain needle sensations and support anxiety instead

What is Electromyography (EMG)?

Electromyography (EMG) is a test that measures muscle electrical activity using fine needles inserted into selected muscles. per the National Institute of Neurological Disorders and Stroke (NINDS), EMG is often performed with nerve conduction studies to help determine whether weakness, numbness, or pain comes from muscle disease, nerve injury, or nerve-root compression.

Overview

Nurses encounter EMG referrals in outpatient neurology clinics, neurophysiology laboratories, and inpatient units when patients have progressive weakness, foot drop, cramps, or sensory changes. The NHS describes EMG as a test that can show how well muscles respond to nerve signals. Nurses coordinate screening, skin preparation, transport, post-needle bleeding checks, and communication when results may change neurologic management.

Unlike bedside strength testing alone, EMG and nerve conduction studies provide objective electrophysiology data that may separate peripheral neuropathy from myopathy or focal entrapment when interpreted with history and examination. Nurses should not label the final diagnosis โ€” but should recognize when prep errors, anticoagulation, cool limbs, or implanted devices make the study unsafe or invalid until clarified with the neurophysiology team.

Clinical Nursing Focus

Before EMG, confirm anticoagulation and implanted-device history, ensure lotion-free skin and warm extremities, and document progressive weakness onset. After testing, monitor needle sites for bleeding or expanding hematoma, reinforce activity guidance, and escalate rapidly worsening weakness or new respiratory symptoms according to facility policy.

Needle EMG, Anticoagulation, and Device Screening Safety

Needle EMG and nerve conduction studies require anticoagulation and implanted-device screening, lotion-free skin, and warm extremities for valid recordings. Progressive weakness with bulbar or respiratory symptoms is a time-sensitive neurologic concern โ€” nurses must not treat abnormal preliminary findings as routine when symptoms are worsening or post-needle bleeding is not controlled.

Highest-risk scenarios
  • Therapeutic anticoagulation without clearance for needle EMG
  • Pacemaker or ICD history without device-team clearance before nerve stimulation
  • Lotion or oil on skin and cool extremities producing invalid nerve conduction data
  • Rapidly progressive weakness, new dysphagia, or respiratory decline
  • Expanding hematoma or uncontrolled bleeding after needle insertion

Document: anticoagulation plan, device clearance, skin prep, limb warmth, needle-site assessment, and escalation calls.

What Electromyography (EMG) Can and Cannot Tell You

This test can help identify:

  • Nerve versus muscle patterns contributing to weakness, cramps, or foot drop
  • Focal entrapment or generalized peripheral neuropathy on nerve conduction studies
  • Denervation or myopathic motor-unit changes on needle EMG
  • Need for neurology follow-up when electrophysiology supports active nerve injury

This test cannot:

  • Diagnose every cause of weakness without clinical and imaging correlation
  • Replace anticoagulation or device screening before needle insertion
  • Produce valid nerve conduction data through lotion-covered or cold limbs
  • Rule out rapidly progressive neuromuscular emergencies when symptoms are worsening

Pre-procedure Checks Before EMG and NCS

Verify

โœ“Correct patient and EMG/NCS order with symptomatic limb documented
โœ“Anticoagulant, antiplatelet, and bleeding-disorder history reviewed
โœ“Pacemaker, ICD, or implanted electrical device clearance when required
โœ“Skin free of lotions, creams, and oils on test day
โœ“Extremities warm enough for valid nerve conduction recordings
โœ“Progressive weakness onset and foot-drop pattern charted

Clarify before proceeding when:

  • Apixaban, warfarin, or antiplatelet therapy lacks documented clearance for needle EMG
  • Patient applied lotion or oil to limbs scheduled for surface electrode placement
  • Limb is cool with delayed capillary refill and warming has not been attempted
  • Pacemaker or ICD history is present without device-team guidance for nerve stimulation
  • Weakness is rapidly progressive with new bulbar or respiratory symptoms
  • Patient cannot cooperate and sedation or rescheduling has not been arranged
  • Prior normal bedside exam conflicts with worsening foot drop โ€” confirm urgency pathway

Reading EMG and NCS Reports With Neurologic Context

Integrate EMG and nerve conduction reports with weakness onset, examination, medications, and imaging. One visit does not define the full neurologic trajectory โ€” trends, validity factors, and symptoms matter.

PatternMay suggestNursing focus
Slowed conduction / conduction blockFocal entrapment or demyelinating neuropathyNeurology follow-up; activity and fall precautions
Denervation potentials on EMGActive nerve injuryMonitor progression; escalate if weakness worsens
Myopathic motor-unit changesPrimary muscle diseaseCoordinate rheumatology or neurology per pathway
Normal study with progressive symptomsEarly disease, wrong segment tested, or invalid prepDo not dismiss symptoms โ€” repeat exam and discuss re-testing
โ†” On a small screen, swipe or scroll sideways to see the full table.

Skin Prep, Warmth, and Anticoagulation at the Bedside

Bedside pointNursing note
Lotion-free skinNHS advises no oils or creams โ€” invalid NCS may delay diagnosis
Warm the limbCool calves can mimic neuropathy until adequately warmed
Anticoagulation clockDocument last apixaban dose and clearance โ€” do not self-hold
Pacemaker screenDevice clearance before electrical stimulation per protocol
NCLEX trapNormal strength in one muscle group does not rule out foot drop from peroneal injury
Evaluate outcomesRepeat dorsiflexion strength after intervention โ€” did foot drop improve?
โ†” On a small screen, swipe or scroll sideways to see the full table.

EMG in Outpatient Neurology and Inpatient Referral Pathways

Diagnostic safety badge: Minimally invasive procedure โ€” anticoagulation, device, skin-prep, and bleeding-surveillance checks apply; rapidly progressive weakness upgrades to urgent neurology pathway.

Check-before-test protocol

  1. Identity + order + symptomatic limb
  2. Anticoagulation and bleeding-risk screening
  3. Implanted electrical device clearance
  4. Lotion-free skin and limb warming
  5. Post-needle bleeding plan and result communication

Critical teach-back questions

  • “Can you tell me when you first noticed the foot drop or leg weakness?”
  • “Which symptoms โ€” trouble breathing, swallowing, or rapidly worsening weakness โ€” should you report right away?”
  • “What should you do if a needle site keeps bleeding or the bruise keeps growing?”

Care coordination: primary prescriber, neurology, neurophysiology, device team when indicated, and rehabilitation services when weakness affects mobility.

Electromyography (EMG) Quick Safety Checklist

  • Was anticoagulation and device screening completed before needle EMG?
  • Was skin lotion-free and the limb warm enough for valid nerve conduction studies?
  • Did progressive foot drop receive neurology follow-up rather than passive monitoring alone?
  • Were needle sites assessed for bleeding or expanding hematoma after the procedure?
  • Did symptoms worsen after testing โ€” requiring re-evaluation before the formal report arrived?

Why Electromyography (EMG) is Ordered

EMG is ordered when clinicians need electrophysiology data to localize nerve versus muscle disease beyond examination alone.

Clinical Indication What the Test Answers Nursing Rationale
Progressive weakness or foot drop Is weakness due to nerve, muscle, or neuromuscular junction disease? Supports evaluation of motor patterns that may reflect diabetic neuropathy, radiculopathy, or myopathy per NINDS indications.
Numbness or sensory change in a limb Is there objective nerve dysfunction matching reported symptoms? Pairs with history of tingling and may guide targeted therapy when focal entrapment or polyneuropathy is suspected.
Suspected myopathy or inflammatory muscle disease Do spontaneous or insertional muscle potentials suggest primary muscle pathology? EMG can help distinguish myopathy from neuropathy when weakness is diffuse or proximal.
Differentiating neurologic mimics of weakness Could neuromuscular junction or central disease explain fluctuating weakness? May be paired with acetylcholine receptor antibody testing when myasthenia gravis or multiple sclerosis remain in the differential per prescriber pathway.
โ†” On a small screen, swipe or scroll sideways to see the full table.

Contraindications and Precautions

There is no single absolute contraindication to all EMG, but needle study should be deferred or modified when bleeding risk is unmanaged, implanted electrical devices require specialist clearance, skin is contaminated with oils, or the limb is too cold for valid nerve conduction recordings.

When EMG may be unsafe or misleading
  • Therapeutic anticoagulation or recent antiplatelet loading without prescriber clearance for needle EMG โ€” bleeding risk may outweigh same-day study benefit.
  • Lotion, cream, or oil on skin โ€” poor electrode contact can invalidate nerve conduction studies per NHS and standard clinical references preparation guidance.
  • Cool or vasoconstricted extremities โ€” nerve conduction amplitudes and velocities may appear falsely abnormal until the limb is warmed.
Patient and device factors
  • Pacemaker or implanted cardioverter-defibrillator history โ€” electrical stimulation during nerve conduction studies requires device-specific clearance per institutional protocol.
  • Bleeding disorders or thrombocytopenia โ€” heightened needle-site hematoma risk.
  • Inability to cooperate or severe pain with needle insertion โ€” may require rescheduling or sedation planning per neurophysiology service.
Escalate If
  • Rapidly progressive weakness, new bulbar symptoms, or respiratory effort decline โ€” escalate to responsible clinician before routine outpatient timing alone.
  • Expanding hematoma, uncontrolled bleeding, or severe pain after needle EMG โ€” urgent medical review.
  • EMG report suggesting acute denervation with clinical deterioration โ€” coordinate neurology follow-up and repeat examination per facility policy.

Patient Preparation

Preparation focuses on anticoagulation and device screening, lotion-free skin, limb warmth, symptom documentation, and patient coaching about needle sensations.

Pre-test checks
โœ“Verify order, indication, and which limb(s) or muscles are symptomatic.
โœ“Document weakness onset and whether symptoms are progressive.
โœ“Review anticoagulants, antiplatelets, and bleeding-disorder history.
โœ“Confirm pacemaker, ICD, or other implanted electrical device history.
โœ“Ensure skin is free of lotions, creams, and oils on the day of testing.
โœ“Explain brief needle discomfort, possible muscle soreness afterward, and the need to report bleeding or expanding bruising.
Medications to Review or Hold

Review apixaban, warfarin, aspirin, clopidogrel, and other antithrombotics with the prescriber or neurophysiology service before needle EMG. Do not hold prescribed anticoagulation without orders โ€” document last dose and clearance plan.

Where the test is performed

This page is a Tests & Diagnostics guide for Electromyography (EMG). It emphasizes why the test is ordered, how to interpret results, when to escalate, and preparation factors that affect validity โ€” not step-by-step performance technique (those live under Nursing Procedures when available).

Electromyography (EMG) is performed in neurophysiology or neurology clinic settings by trained specialists, often together with nerve conduction studies. Ward and clinic nurses focus on indication checks, anticoagulation and implanted-device screening, skin preparation that affects electrode contact, transport, post-procedure bleeding surveillance, and acting on results that change neurologic management โ€” not needle placement or electrodiagnostic acquisition.

Use the preparation, results, and nursing responsibility sections below for safety checks, interpretation, escalation, and documentation โ€” not equipment operation or departmental imaging protocols.

Result follow-up at a glance

Nursing workflow on this page โ€” from order to safe action on results:

1
Confirm indication & correct order
2
Coordinate with laboratory or radiology per local policy
3
Document pre-analytic preparation & timing
4
Review result with trend & clinical picture
5
Escalate critical or discordant findings
6
Document communication & patient teaching

Results and Interpretation

EMG and nerve conduction study results are reported as descriptive electrophysiology findings โ€” for example reduced conduction velocity, conduction block, fibrillation potentials, or myopathic motor-unit changes. standard clinical references and NINDS emphasize interpretation by a trained specialist in context of examination and history. Nurses correlate reports with symptoms and escalation pathways rather than applying universal numeric cutoffs.

Reference Range Disclaimer

Reference ranges, critical values, and protocols may vary by laboratory, institution, patient population, and testing method. Always follow local policy and the reporting laboratory’s reference range.

Result Range / Finding Clinical Meaning Nursing Action
No acute critical finding / as expected for indication Normal nerve conduction parameters and quiet resting muscle activity on EMG No electrophysiologic evidence of significant nerve or muscle pathology in tested segments Continue symptom surveillance; follow prescriber plan if symptoms persist
Equivocal / indeterminate finding Mild or focal changes of uncertain clinical significance May require correlation with examination, repeat study, or additional imaging Communicate to neurology; avoid dismissing progressive symptoms because findings are mild
Abnormal finding โ€” clinically significant Definite denervation, conduction block, or myopathic patterns on EMG/NCS May support peripheral neuropathy, radiculopathy, entrapment neuropathy, or myopathy depending on distribution โ€” final diagnosis requires specialist synthesis. Communicate to prescriber/neurology; reinforce activity and fall precautions when weakness is progressive; arrange follow-up testing per pathway
Not applicable Not applicable โ€” EMG/NCS reports describe patterns and amplitudes, not low laboratory numeric values Not applicable for electrophysiology reporting Interpret using distribution, symptoms, and specialist report
โ†” On a small screen, swipe or scroll sideways to see the full table.

Urgent Findings and Escalation

EMG does not use laboratory critical values. Urgent nursing action depends on progressive weakness, respiratory symptoms, uncontrolled bleeding after needles, and rapid clinical deterioration.

Critical Finding Threshold / Value Immediate Action
Rapidly progressive weakness with bulbar or respiratory symptoms New dysphagia, dysarthria, neck weakness, or declining vital capacity Escalate to responsible clinician/neurology immediately per facility policy โ€” do not delay for routine outpatient EMG reporting alone
Expanding hematoma or uncontrolled bleeding after needle EMG Growing bruise, continued oozing, or severe pain at needle sites Apply direct pressure per protocol, notify prescriber, and obtain urgent medical review
Invalid study driving major decisions Lotion-contaminated skin, cold limb, or incomplete device clearance Do not conclude absence of neuropathy from invalid data โ€” repeat after correction per neurophysiology guidance
โ†” On a small screen, swipe or scroll sideways to see the full table.
Stop and Escalate

Stop routine scheduling and escalate according to facility policy when weakness is rapidly progressive, respiratory effort declines, or post-procedure bleeding is not controlled โ€” even if EMG is incomplete or report is pending.

Factors Affecting Results

EMG and nerve conduction validity can be affected by skin prep, temperature, edema, and recent limb trauma.

False Positives
  • Cool extremities mimicking neuropathy until adequately warmed
  • Lotion or oil reducing surface electrode contact during NCS
  • Recent strenuous exercise causing transient muscle irritability
False Negatives
  • Early neuropathy with symptoms outpacing electrophysiologic changes
  • Focal study missing clinically involved muscles or nerves
  • Edema or obesity limiting adequate needle access to target muscles
Interfering Factors
  • Anticoagulation increasing bleeding without changing nerve physiology
  • Implanted devices requiring modified stimulation protocols
  • Anxiety or pain limiting voluntary muscle activation during EMG
Test Limitations

EMG does not diagnose every cause of weakness, does not replace imaging when structural cord or root compression is suspected, and may be normal early in some neuropathies. A normal study does not exclude neuromuscular junction disorders without appropriate serologic and clinical correlation. Turnaround and screening rules vary by institution; follow local institutional policy for universal screening cutoffs across all age groups.

Nursing Responsibilities

Nursing care centers on safe screening, valid prep, post-needle bleeding surveillance, patient teaching, and timely escalation of progressive weakness.

Before the Test
โœ“Review indication, limb involved, and weakness onset
โœ“Screen anticoagulation, bleeding risk, and implanted devices
โœ“Confirm lotion-free skin and plan limb warming when needed
โœ“Coordinate transport and anxiety support for needle study
During the Test
โœ“Maintain privacy and positioning for neurophysiology access
โœ“Observe for vasovagal symptoms during nerve stimulation or needles
โœ“Document device clearance and anticoagulation plan before needles
After the Test
โœ“Inspect needle sites and apply pressure per protocol
โœ“Communicate progressive weakness to prescriber even if report pending
โœ“Reinforce bleeding precautions and activity guidance
โœ“Teach when to report expanding bruising, new foot drop, or dyspnea

Documentation

Clear documentation supports safe needle EMG, valid nerve conduction recordings, and neurology follow-up.

Example Nursing Note

“EMG/NCS referral verified 0900. 62-year-old male reports 6-week progressive right foot drop; apixaban 5 mg BID โ€” prescriber cleared same-day study with plan documented. Pacemaker history noted; device team clearance on chart. Lotion removed from calves; limbs warmed 15 min before NCS. Tolerated study with brief needle discomfort; needle sites dry with small ecchymoses. Patient taught to report expanding bruising or worsening weakness. Neurology follow-up appointment confirmed.”

Key Documentation Points
  • Indication, limb involved, and weakness onset timeline
  • Anticoagulation/device screening and clearance plan
  • Skin prep, limb warmth measures, and cooperation notes
  • Post-procedure needle-site assessment and symptoms
  • Urgent communication and read-back when required by policy
  • Teaching on bleeding precautions and return precautions

Patient and Family Education

Use plain language; emphasize that brief needle discomfort is expected and that reporting bleeding or worsening weakness matters after the visit.

โœ“Explain why muscles and nerves are tested and that small needles record electrical signals
โœ“Describe nerve stimulation sensations and brief muscle soreness afterward per NHS guidance
โœ“Ask about lotion use and instruct to arrive with clean, dry skin
โœ“Review anticoagulation plans โ€” do not stop medicines without prescriber orders
โœ“Clarify that results may take specialist interpretation after the session
โœ“Provide written follow-up instructions when available; confirm how results will be communicated
๐Ÿ“š

Electromyography (EMG) NCLEX practice questions

Practice NCLEX-style clinical judgment focused on Electromyography (EMG) safety and nursing judgment. Use the case tabs (orders, results, assessment, nursing notes), then answer eight Next Genโ€“style items (including an ordered workflow step) and evaluate outcomes with the answer key.

Select a tab to view orders, results, assessment, and nursing note details for this case.

  • Order: Right lower-extremity EMG with nerve conduction studies; neurology follow-up pending
  • Indication: 62-year-old male โ€” progressive right leg weakness and foot drop ร— 6 weeks
  • Timing: Outpatient neurophysiology appointment 1000; patient arrived with lotion on calves
  • Related orders: Apixaban 5 mg BID; history of pacemaker (2019); BMP and A1c on chart
Question 1 โ€” Priority action

After reviewing the case tabs, what is the nurse’s priority action before EMG/NCS proceeds?

Question 2 โ€” Recognize cues

Which findings from the case tabs should prompt the nurse to clarify or escalate before routine follow-up only? Select all that apply. Select all that apply

Question 3 โ€” Trend interpretation

Which trends are most concerning when evaluating whether the plan is working? Select all that apply.

Trend snapshot
Ankle dorsiflexion 3/5 today vs 4/5 documented 2 weeks ago; calf lotion noted on exam

Select all that apply

Question 4 โ€” Matrix judgment

Classify each finding for this patient:

Finding Expected โ€” document and continue monitoring Requires follow-up โ€” notify team / repeat test Urgent โ€” immediate escalation
Stable vitals, mild cramping only, and non-progressive symptoms per patient report
Lotion on calves and cool right extremity before nerve conduction testing
Rapidly progressive bilateral leg weakness with new dyspnea
Small stable ecchymoses at needle sites with controlled bleeding after EMG

On a small screen, swipe or scroll sideways to see the full table.

Question 5 โ€” Clinical judgment

A colleague says EMG should start now because the patient already arrived and warming the limb will waste clinic time. What is the best response?

Question 6 โ€” Documentation (cloze)

Complete the priority documentation phrase after today’s EMG referral visit:

The highest-priority documentation action is .

Question 7 โ€” Workflow (ordered response)

Before EMG with needle study for progressive leg weakness, rank the nurse’s actions (1 = first).

  1. Verify identity, indication, and that EMG/NCS matches the symptomatic limbs
  2. Review anticoagulant, bleeding-disorder, and pacemaker history with neurophysiology per protocol
  3. Ensure skin is free of lotions and limbs are warm enough for valid recordings
  4. Reassess the patient, verify the order and identity, and prepare for prescriber follow-up
Question 8 โ€” Evaluate outcomes

Two hours after needle EMG, the patient reports a rapidly expanding bruise, increasing pain at the insertion site, and new foot weakness. What is the best nursing action?

Answer key & rationale

Frequently Asked Questions

FAQ

What is the difference between EMG and nerve conduction studies?

In practice, nerve conduction studies measure how well nerves send electrical signals using surface electrodes and small shocks, while needle EMG records muscle electrical activity at rest and during contraction. They are often performed together to localize nerve versus muscle disease.

Does EMG diagnose the cause of weakness?

No. EMG and nerve conduction studies provide electrophysiology patterns that specialists integrate with history, examination, imaging, and laboratory studies. Nurses support referral and follow-up rather than assigning final diagnoses.

Why must skin be free of lotion before EMG?

The NHS advises clean, dry skin without oils or creams so surface electrodes make proper contact during nerve conduction studies. Lotion can invalidate recordings and delay accurate interpretation.

How should anticoagulation be handled before needle EMG?

bleeding risk with needle insertion. Nurses document anticoagulant and antiplatelet medicines and follow prescriber or neurophysiology clearance plans โ€” do not stop prescribed therapy without orders.

Why does limb temperature matter for nerve conduction studies?

Cool extremities can slow conduction and reduce amplitudes, mimicking neuropathy. NHS and clinical references recommend warming limbs when needed so results reflect true nerve function.

What related tests are often ordered with EMG?

Nerve conduction studies are commonly performed in the same visit. Imaging, laboratory studies, and serologic tests may follow depending on suspected neuropathy, myopathy, or neuromuscular junction disease per prescriber pathway.

When should nurses escalate after EMG?

Escalate expanding hematoma, uncontrolled needle-site bleeding, rapidly progressive weakness, or new bulbar or respiratory symptoms according to facility policy โ€” even if the formal electrophysiology report is still pending.

References

References
  1. MedlinePlus. Electromyography (EMG). U.S. National Library of Medicine.
    https://medlineplus.gov/lab-tests/electromyography-emg/
  2. National Institute of Neurological Disorders and Stroke. Electromyography (EMG). NIH.
    https://www.ninds.nih.gov/health-information/disorders/electromyography-emg
  3. National Health Service. Electromyography (EMG). NHS.uk.
    https://www.nhs.uk/tests-and-treatments/electromyography-emg/
  4. MedlinePlus Medical Encyclopedia. Electromyography. U.S. National Library of Medicine.
    https://medlineplus.gov/ency/article/003929.htm
  5. National Institute of Neurological Disorders and Stroke. Peripheral Neuropathy. NIH.
    https://www.ninds.nih.gov/health-information/disorders/peripheral-neuropathy
  6. National Health Service. Nerve conduction studies. NHS.uk.
    https://www.nhs.uk/tests-and-treatments/nerve-conduction-studies/
  7. National Institute of Neurological Disorders and Stroke. Muscle Cramp. NIH.
    https://www.ninds.nih.gov/health-information/disorders/muscle-cramp
  8. MedlinePlus. Nerve Conduction Studies. U.S. National Library of Medicine.
    https://medlineplus.gov/lab-tests/nerve-conduction-studies/

Editorial Standards & Medical Review

About the author: Sid A. Abdala Balal, RN, writes evidence-based nursing education focused on diagnostic safety, clinical interpretation, and bedside nursing judgment.

Medical review: This guide is reviewed by Dr. Adam Sayedi, MD, for clinical accuracy, diagnostic safety, and alignment with current standards for Electromyography (EMG).

Policies: Medical Review Process ยท Editorial Policy ยท Correction Policy